Nasment (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride is a topical alpha‑adrenergic agonist. When applied to the nasal lining, it stimulates α‑adrenergic receptors on blood vessels, causing vasoconstriction. This narrows the vessels, decreases blood flow and edema, and opens the nasal passages for easier breathing.

The specific dosing regimen for Nasment is determined by the prescribing healthcare professional. Typically, a few sprays per nostril are used, but the exact number and frequency should follow the prescriber’s instructions and the product label.

Safety data for Xylometazoline Hydrochloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their physician before using Nasment.

To order Nasment, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasment’s active ingredient, Xylometazoline, belongs to the imidazoline class, which provides rapid vasoconstriction similar to phenylephrine‑based sprays. Compared with oxymetazoline, Xylometazoline has a comparable onset of action but may have a slightly lower incidence of rebound congestion when used as directed.

Store Nasment at room temperature, preferably below 25 °C. Keep the bottle tightly closed in its original packaging, protect it from moisture and direct sunlight, and keep it out of reach of children.

Nasment is applied directly into each nostril using the spray pump. The user should tilt the head slightly forward, insert the nozzle into the nostril, and press the pump to deliver the recommended number of sprays. Avoid blowing the nose immediately after application.

Serious but rare risks include persistent hypertension, severe nasal ulceration, and allergic reactions such as anaphylaxis. Prolonged use beyond 3‑5 days can cause rebound congestion, which may worsen nasal blockage when the product is stopped.

Nasment should be avoided in individuals with known hypersensitivity to Xylometazoline or any formulation components, in children under two years of age unless directed by a physician, and in patients with uncontrolled hypertension or severe cardiovascular disease without medical supervision.